MedTrace Logo

The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td

NCT01338688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2011-04-19

No results posted yet for this study

Summary

The investigators want to determine whether TIG influences the formation of tetanus antibody after simultaneous tetanus vaccination according to age and the time-interval of the last tetanus vaccination.

Conditions

  • Tetanus

Sponsors & Collaborators

  • Seoul National University Boramae Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • JongHwan Shin · Seoul National University Boramae Hospital

Eligibility

Min Age
20 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-04-30
Completion
2010-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01338688 on ClinicalTrials.gov